CMMB vs ZION · $22.2M cap vs P/E 11, rev $354.0M
Chemomab Therapeutics Ltd DRC (CMMB) versus Zions Bancorporation (ZION) — a side-by-side from cached financials, not a winner call.
Chemomab Therapeutics Ltd DRC (CMMB) is a biotechnology company listed on US.
Zions Bancorporation (ZION) is a banks - regional company listed on US.
CMMB does not have a complete income-statement cache yet.
Latest reported ZION revenue for 2026-06-30 was $354.0M. Net income was $686.0M. ZION currently screens at market cap $8.19B and trailing P/E 10.8.
CMMB currently screens at market cap $22.2M. ZION currently screens at market cap $8.19B and trailing P/E 10.8.
Not investment advice. Open the CMMB and ZION stock pages for the full models.
Not investment advice.